510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1453-2014Class I

Pipeline Embolization Device (PED). Used endovascular treatment of adults with intracranial aneurysms in the...

Medtronic, Inc. / initiated 2014-04-01 / Terminated

Micro Therapeutics Inc, Dba Ev3 Neurovascular began a recall of Pipeline Embolization Device (PED). Used endovascular treatment of adults with intracranial aneurysms in the internal carotid artery on . FDA classified it as Class I and gives the reason as "Potential for the PTFE (polytetrafluoroethylene) coating to delaminate and detach from the delivery wire". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-1453-2014
Classification
Class I
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Medtronic, Inc.
Product
Pipeline Embolization Device (PED). Used endovascular treatment of adults with intracranial aneurysms in the internal carotid artery.
Product code
DQY Catheter, Percutaneous
Reason for recall
Potential for the PTFE (polytetrafluoroethylene) coating to delaminate and detach from the delivery wire.
FDA root cause
Process change control
Action
A customer notification letter was sent on 4/1/14 to all customers who purchased the Pipeline Embolization Device and the Alligator Retrieval Device. The letter informs the customers of the problems identified and the actions to be taken. Customers are instructed to complete the customer response form and fax the completed form to Covidien at (763) 591-3519. Customers with questions are instructed to contact Dr. Mark A. Turco at (202) 310-5120. A press release was sent on 4/11/14 to Business Wire Newsroom to inform the public about the recall from Covidien. The recall is regarding certain lots of its Pipeline Embolization Device and Alligator Retrieval Device where the polytetrafluoroethylene (PTFE) coating applied to the delivery wire could delaminate adn detach from the devices. Consumers are instructed to report any adverse reactions or quality problems experienced with the use of the product to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Consumers with may also contact Covidien Customer Service at (800) 716-6700 between 7am to 7pm (central) or email at [email protected].
Quantity in commerce
32 units total (23 units in US)
Distribution
Worldwide Distribution-USA (nationwide) including Puerto Rico and the countries of Australia, Germany, France, UK, Turkey, Argentina, Canada, Colombia, Mexico, , Austria, Belgium, Denmark, Hungary, Italy, Netherlands, Norway, Poland, Portugal, Russia, Slovakia, Slovenia, Spain, Switzerland, and UAE.
Product codes and lots
PED Model/ Lot  FA7735014 / 9879718  FA7742512 / 9864827 FA7150035 / 9855921 FA7735016 / 9856429  FA7742518 / 9856431 FA7730010 / 9869991  FA7737514 / 9855933  FA7742518 / 9860762 FA7732514 / 9873854  FA7737516 / 9858010  FA7745014 / 9874111 FA7735014 / 9855265  FA7740016 / 9859214  FA7745016 / 9879736 FA7735014 / 9875267  FA7740016 / 9879180  FA7747514 / 9868888

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1453-2014
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1453-2014Class ITerminatedVoluntary: Firm initiated
Z-1454-2014Class ITerminatedVoluntary: Firm initiated